Biogen

Biogen: Carbon Emissions and Climate Commitments

Biogen, a pharmaceutical preparation manufacturing company headquartered in the US, is actively engaged in reducing its environmental impact. The company has set ambitious targets for emissions reduction, aiming for net-zero across its value chain by 2045.

Emissions Data:

• 2025: Biogen reported total global emissions of approximately 356,224,000 kg CO2e. This includes Scope 1 emissions of about 56,948,000 kg CO2e, Scope 2 emissions (market-based) of approximately 1,507,000 kg CO2e, and Scope 3 emissions totalling around 297,768,000 kg CO2e. Purchased goods and services represented the largest component of Scope 3 emissions, at approximately 214,394,000 kg CO2e.
• 2024: Total global emissions were approximately 324,178,000 kg CO2e. Scope 1 emissions were about 56,611,000 kg CO2e, Scope 2 (market-based) emissions were approximately 507,000 kg CO2e, and Scope 3 emissions stood at roughly 267,104,000 kg CO2e.
• 2023: Global emissions were reported at approximately 361,715,000 kg CO2e, comprising Scope 1 emissions of about 57,237,000 kg CO2e, Scope 2 (market-based) of approximately 373,000 kg CO2e, and Scope 3 emissions of around 304,105,000 kg CO2e.
• 2022: Total global emissions were approximately 499,837,000 kg CO2e, with Scope 1 emissions at about 64,867,000 kg CO2e, Scope 2 (market-based) at approximately 335,000 kg CO2e, and Scope 3 emissions totalling around 434,635,000 kg CO2e.
• 2021: Global emissions were approximately 469,909,000 kg CO2e, including Scope 1 emissions of about 63,182,000 kg CO2e, Scope 2 (market-based) of roughly 268,000 kg CO2e, and Scope 3 emissions at around 406,442,000 kg CO2e.
• 2020: Total global emissions were approximately 406,139,000 kg CO2e, with Scope 1 at about 57,553,000 kg CO2e, Scope 2 (market-based) at approximately 280,000 kg CO2e, and Scope 3 emissions totalling around 348,911,000 kg CO2e.
• 2019: Global emissions amounted to approximately 491,545,000 kg CO2e. Scope 1 emissions were about 67,031,000 kg CO2e, Scope 2 (market-based) were approximately 131,000 kg CO2e, and Scope 3 emissions were around 424,592,000 kg CO2e.

Climate Commitments and Reduction Targets:

Biogen has established several significant climate targets, aligning with a 1.5°C pathway:

• Net-Zero Ambition: The company aims to achieve net-zero GHG emissions across its value chain by 2045.
• Scope 1 and 2 Reduction: Biogen has committed to reducing absolute Scope 1 and 2 GHG emissions by 55% by 2032, using a 2019 baseline. Furthermore, it aims for a 100% reduction in absolute Scope 1 and 2 GHG emissions by 2040.
• Supplier Engagement: A key near-term target is to ensure that 80% of its suppliers by spend, covering purchased goods and services and capital goods, will have science-based targets by 2025.
• Near-Zero Operations: Biogen also aims to reduce its Scope 1 and 2 emissions to near zero by the middle of this decade and to achieve net-zero market-based Scope 2 emissions by 2030.

These commitments demonstrate Biogen's dedication to environmental stewardship within the pharmaceutical preparation manufacturing industry.